Antihypertensive treatment and new-onset diabetes mellitus

Tonje Amb Aksnes, Henrik M. Reims, Sverre E. Kjeldsen, Giuseppe Mancia

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by thiazide diuretics and β-adrenergic blockers, and unchanged or decreased by angiotensin-converting enzyme inhibitors, calcium channel blockers, and angiotensin-receptor blockers. The differences in new-onset diabetes mellitus have not influenced the outcome of cardiovascular mortality and morbidity in all of the large clinical trials, but drug-induced diabetes among hypertensive patients is known to carry the same cardiovascular risk as that seen in patients with previously known diabetes; however, it might take years for the increased risk to become apparent.

Original languageEnglish
Pages (from-to)298-303
Number of pages6
JournalCurrent Hypertension Reports
Volume7
Issue number4
Publication statusPublished - Aug 2005

Fingerprint

Antihypertensive Agents
Diabetes Mellitus
Sodium Chloride Symporter Inhibitors
Adrenergic Antagonists
Angiotensin Receptor Antagonists
Calcium Channels
Angiotensin-Converting Enzyme Inhibitors
Clinical Trials
Hypertension
Morbidity
Glucose
Drug Therapy
Mortality
Incidence
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Aksnes, T. A., Reims, H. M., Kjeldsen, S. E., & Mancia, G. (2005). Antihypertensive treatment and new-onset diabetes mellitus. Current Hypertension Reports, 7(4), 298-303.

Antihypertensive treatment and new-onset diabetes mellitus. / Aksnes, Tonje Amb; Reims, Henrik M.; Kjeldsen, Sverre E.; Mancia, Giuseppe.

In: Current Hypertension Reports, Vol. 7, No. 4, 08.2005, p. 298-303.

Research output: Contribution to journalArticle

Aksnes, TA, Reims, HM, Kjeldsen, SE & Mancia, G 2005, 'Antihypertensive treatment and new-onset diabetes mellitus', Current Hypertension Reports, vol. 7, no. 4, pp. 298-303.
Aksnes TA, Reims HM, Kjeldsen SE, Mancia G. Antihypertensive treatment and new-onset diabetes mellitus. Current Hypertension Reports. 2005 Aug;7(4):298-303.
Aksnes, Tonje Amb ; Reims, Henrik M. ; Kjeldsen, Sverre E. ; Mancia, Giuseppe. / Antihypertensive treatment and new-onset diabetes mellitus. In: Current Hypertension Reports. 2005 ; Vol. 7, No. 4. pp. 298-303.
@article{4a2e924cbe5345f18135cd75b73b68b1,
title = "Antihypertensive treatment and new-onset diabetes mellitus",
abstract = "The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by thiazide diuretics and β-adrenergic blockers, and unchanged or decreased by angiotensin-converting enzyme inhibitors, calcium channel blockers, and angiotensin-receptor blockers. The differences in new-onset diabetes mellitus have not influenced the outcome of cardiovascular mortality and morbidity in all of the large clinical trials, but drug-induced diabetes among hypertensive patients is known to carry the same cardiovascular risk as that seen in patients with previously known diabetes; however, it might take years for the increased risk to become apparent.",
author = "Aksnes, {Tonje Amb} and Reims, {Henrik M.} and Kjeldsen, {Sverre E.} and Giuseppe Mancia",
year = "2005",
month = "8",
language = "English",
volume = "7",
pages = "298--303",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Antihypertensive treatment and new-onset diabetes mellitus

AU - Aksnes, Tonje Amb

AU - Reims, Henrik M.

AU - Kjeldsen, Sverre E.

AU - Mancia, Giuseppe

PY - 2005/8

Y1 - 2005/8

N2 - The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by thiazide diuretics and β-adrenergic blockers, and unchanged or decreased by angiotensin-converting enzyme inhibitors, calcium channel blockers, and angiotensin-receptor blockers. The differences in new-onset diabetes mellitus have not influenced the outcome of cardiovascular mortality and morbidity in all of the large clinical trials, but drug-induced diabetes among hypertensive patients is known to carry the same cardiovascular risk as that seen in patients with previously known diabetes; however, it might take years for the increased risk to become apparent.

AB - The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by thiazide diuretics and β-adrenergic blockers, and unchanged or decreased by angiotensin-converting enzyme inhibitors, calcium channel blockers, and angiotensin-receptor blockers. The differences in new-onset diabetes mellitus have not influenced the outcome of cardiovascular mortality and morbidity in all of the large clinical trials, but drug-induced diabetes among hypertensive patients is known to carry the same cardiovascular risk as that seen in patients with previously known diabetes; however, it might take years for the increased risk to become apparent.

UR - http://www.scopus.com/inward/record.url?scp=24944580949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944580949&partnerID=8YFLogxK

M3 - Article

C2 - 16061050

AN - SCOPUS:24944580949

VL - 7

SP - 298

EP - 303

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 4

ER -